Raising growth investment funds through the issuance and exercise of stock acquisition rights
First written in FY2018-Q3. 1 of 4 entries say "Achieved", first in FY2018. Latest entry: FY2022-Q3.
6 other companies' latest entry also says "Other".
- FY2022-Q3Acquisition and cancellation of remaining stock acquisition rightsAnnual report
「With respect to the Fifth Series Stock Acquisition Rights, the Company acquired all stock acquisition rights remaining as of 24 December 2021 and immediately cancelled all of the acquired rights.」
On 24 December 2021, the Company acquired all remaining Fifth Series Stock Acquisition Rights and immediately cancelled them. - FY2021-Q2AdvancedAnnual report
「At a meeting of the Board of Directors held on 8 September 2020, the Company resolved to issue stock acquisition rights through a third-party allotment to Nomura Securities Co., Ltd. as the intended allottee, and issued the stock acquisition rights to Nomura Securities Co., Ltd. on 25 September 2020.」
The Company issued 95,000 Fifth Series Stock Acquisition Rights, representing 9,500,000 potential shares, and carried out a new growth-funding initiative with an exercise period from 1 October 2020 through 29 September 2023. - FY2018AchievedAnnual report
「Number of bonds with stock acquisition rights with provisions for adjustment of the exercise price exercised during the fourth quarter accounting period (rights) 70,000 Number of shares delivered upon exercise during the period (shares) 7,000,000 Amount raised through exercises during the period (thousand yen) 9,195,600」
All 70,000 stock acquisition rights issued were exercised, 7,000,000 shares were delivered, and the amount raised was ¥9,195,600 thousand. - FY2018-Q3First statedAnnual report
「Based on a resolution adopted at a meeting of the Board of Directors held on 26 December 2017, the Company issued on 12 January 2018, through a third-party allotment, the Fourth Series of Stock Acquisition Rights with provisions for adjustment of the exercise price and provisions for exercise designation and suspension designation.」
The Company issued 70,000 stock acquisition rights representing 7,000,000 potential shares. By 9 February 2018, 67,000 rights had been exercised, 6,700,000 shares had been issued, and the total exercise price was ¥8,863 million. The funds are being used for new materials, a research and development facility, capital expenditures, and capital and business alliance investments, including future M&A.